Literature DB >> 16829621

Factors associated with immunoglobulin G subclass polarization in naturally acquired antibodies to Plasmodium falciparum merozoite surface proteins: a cross-sectional survey in Brazilian Amazonia.

Kézia K G Scopel1, Cor J F Fontes, Marcelo U Ferreira, Erika M Braga.   

Abstract

We investigated immunoglobulin G (IgG) subclass antibody responses to Plasmodium falciparum merozoite surface protein 1 (MSP-1) and MSP-2 in 112 malaria-exposed subjects in Brazil. IgG3 polarization was primarily epitope driven, being little affected by cumulative or current exposure to malaria and not affected by a subject's age and Fcgamma receptor IIA genotype.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16829621      PMCID： PMC1489569          DOI： 10.1128/CVI.00095-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  30 in total

Review 1.  Antigenic diversity and immune evasion by malaria parasites.

Authors:  Marcelo U Ferreira; Mônica da Silva Nunes; Gerhard Wunderlich
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

2.  Plasmodium falciparum: IgG subclass antibody response to merozoite surface protein-1 among Amazonian gold miners, in relation to infection status and disease expression.

Authors:  Kézia K G Scopel; Cor J F Fontes; Marcelo U Ferreira; Erika M Braga
Journal:  Exp Parasitol       Date:  2005-01-20       Impact factor: 2.011

3.  Humoral immune responses of Solomon Islanders to the merozoite surface antigen 2 of Plasmodium falciparum show pronounced skewing towards antibodies of the immunoglobulin G3 subclass.

Authors:  C M Rzepczyk; K Hale; N Woodroffe; A Bobogare; P Csurhes; A Ishii; A Ferrante
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

4.  IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria.

Authors:  R R Taylor; S J Allen; B M Greenwood; E M Riley
Journal:  Am J Trop Med Hyg       Date:  1998-04       Impact factor: 2.345

5.  Rapid detection of the Fc gamma RIIA-H/R 131 ligand-binding polymorphism using an allele-specific restriction enzyme digestion (ASRED).

Authors:  X M Jiang; G Arepally; M Poncz; S E McKenzie
Journal:  J Immunol Methods       Date:  1996-11-29       Impact factor: 2.303

6.  Differential antibody recognition of four allelic variants of the merozoite surface protein-2 (MSP-2) of Plasmodium falciparum.

Authors:  R Tonhosolo; G Wunderlich; M U Ferreira
Journal:  J Eukaryot Microbiol       Date:  2001 Sep-Oct       Impact factor: 3.346

7.  Fixed, epitope-specific, cytophilic antibody response to the polymorphic block 2 domain of the Plasmodium falciparum merozoite surface antigen MSP-1 in humans living in a malaria-endemic area.

Authors:  H Jouin; C Rogier; J F Trape; O Mercereau-Puijalon
Journal:  Eur J Immunol       Date:  2001-02       Impact factor: 5.532

8.  Regulation of antigen-specific immunoglobulin G subclasses in response to conserved and polymorphic Plasmodium falciparum antigens in an in vitro model.

Authors:  Olivier Garraud; Ronald Perraut; Ababacar Diouf; Wilfrid S Nambei; Adama Tall; André Spiegel; Shirley Longacre; David C Kaslow; Hélène Jouin; Denise Mattei; Gina M Engler; Thomas B Nutman; Eleanor M Riley; Odile Mercereau-Puijalon
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

9.  Polymorphism of the Fcgamma receptor IIA and malaria morbidity.

Authors:  Erika Martins Braga; Kézia Katiani Gorza Scopel; Natália Tiemi Komatsu; Mônica da Silva-Nunes; Marcelo Urbano Ferreira
Journal:  J Mol Genet Med       Date:  2005-07-28

10.  Expression and antigenicity of Plasmodium falciparum major merozoite surface protein (MSP1(19)) variants secreted from Saccharomyces cerevisiae.

Authors:  D C Kaslow; G Hui; S Kumar
Journal:  Mol Biochem Parasitol       Date:  1994-02       Impact factor: 1.759
View more
  10 in total

1.  Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response.

Authors:  Danielle I Stanisic; Freya J I Fowkes; Melanie Koinari; Sarah Javati; Enmoore Lin; Benson Kiniboro; Jack S Richards; Leanne J Robinson; Louis Schofield; James W Kazura; Christopher L King; Peter Zimmerman; Ingrid Felger; Peter M Siba; Ivo Mueller; James G Beeson
Journal:  Infect Immun       Date:  2014-11-24       Impact factor: 3.441

2.  Development of quantitative suspension array assays for six immunoglobulin isotypes and subclasses to multiple Plasmodium falciparum antigens.

Authors:  Marta Vidal; Ruth Aguilar; Joseph J Campo; Carlota Dobaño
Journal:  J Immunol Methods       Date:  2018-01-31       Impact factor: 2.303

3.  Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.

Authors:  Danielle I Stanisic; Jack S Richards; Fiona J McCallum; Pascal Michon; Christopher L King; Sonja Schoepflin; Paul R Gilson; Vincent J Murphy; Robin F Anders; Ivo Mueller; James G Beeson
Journal:  Infect Immun       Date:  2009-01-12       Impact factor: 3.441

4.  Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individuals.

Authors:  J C Lima-Junior; T M Tran; E V S Meyer; B Singh; S G De-Simone; F Santos; C T Daniel-Ribeiro; A Moreno; J W Barnwell; M R Galinski; J Oliveira-Ferreira
Journal:  Vaccine       Date:  2008-12-02       Impact factor: 3.641

5.  Specificity of the IgG antibody response to Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, and Plasmodium ovale MSP119 subunit proteins in multiplexed serologic assays.

Authors:  Jeffrey W Priest; Mateusz M Plucinski; Curtis S Huber; Eric Rogier; Bunsoth Mao; Christopher J Gregory; Baltazar Candrinho; James Colborn; John W Barnwell
Journal:  Malar J       Date:  2018-11-09       Impact factor: 2.979

6.  Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria.

Authors:  Wen-Qiang He; Ahmad Rushdi Shakri; Rukmini Bhardwaj; Camila T França; Danielle I Stanisic; Julie Healer; Benson Kiniboro; Leanne J Robinson; Micheline Guillotte-Blisnick; Christèle Huon; Peter Siba; Alan Cowman; Christopher L King; Wai-Hong Tham; Chetan E Chitnis; Ivo Mueller
Journal:  PLoS Negl Trop Dis       Date:  2019-02-15

7.  Naturally acquired antibody response to a Plasmodium falciparum chimeric vaccine candidate GMZ2.6c and its components (MSP-3, GLURP, and Pfs48/45) in individuals living in Brazilian malaria-endemic areas.

Authors:  Barbara Oliveira Baptista; Ana Beatriz Lopes de Souza; Evelyn Kety Pratt Riccio; Cesare Bianco-Junior; Paulo Renato Rivas Totino; João Hermínio Martins da Silva; Michael Theisen; Susheel Kumar Singh; Linda Eva Amoah; Marcelo Ribeiro-Alves; Rodrigo Medeiros Souza; Josué Costa Lima-Junior; Cláudio Tadeu Daniel-Ribeiro; Lilian Rose Pratt-Riccio
Journal:  Malar J       Date:  2022-01-04       Impact factor: 2.979

8.  Population diversity and antibody selective pressure to Plasmodium falciparum MSP1 block2 locus in an African malaria-endemic setting.

Authors:  Nitchakarn Noranate; Franck Prugnolle; Hélène Jouin; Adama Tall; Laurence Marrama; Cheikh Sokhna; Marie-Thérèse Ekala; Micheline Guillotte; Emmanuel Bischoff; Christiane Bouchier; Jintana Patarapotikul; Jun Ohashi; Jean-François Trape; Christophe Rogier; Odile Mercereau-Puijalon
Journal:  BMC Microbiol       Date:  2009-10-15       Impact factor: 3.605

9.  Evaluation of the genetic polymorphism of Plasmodium falciparum P126 protein (SERA or SERP) and its influence on naturally acquired specific antibody responses in malaria-infected individuals living in the Brazilian Amazon.

Authors:  Lilian Rose Pratt-Riccio; Selma Sallenave-Sales; Joseli de Oliveira-Ferreira; Bruno T da Silva; Monick Lindenmeyer Guimarães; Fátima Santos; Thatiane S de Simone; Mariza G Morgado; Salvatore G de Simone; Maria de Fátima Ferreira-Da-Cruz; Cláudio T Daniel-Ribeiro; Mariano G Zalis; Daniel Camus; Dalma M Banic
Journal:  Malar J       Date:  2008-07-30       Impact factor: 2.979

10.  A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria.

Authors:  Linda M Murungi; Gathoni Kamuyu; Brett Lowe; Philip Bejon; Michael Theisen; Samson M Kinyanjui; Kevin Marsh; Faith H A Osier
Journal:  Vaccine       Date:  2013-06-22       Impact factor: 3.641
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.